Get started
Author

Hsinyu Lin

Observed name: H M Lin
ORCID: 0009-0006-5100-2681
Observed ORCID: 0009-0006-5100-2681
OpenAlex ID: A5046901574
Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression
2022 · Xinyuan Lei, Hsinyu Lin, et al. · Nature Communications · 58
PDF
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results
2025 · Niu Liu, Jiaying Wu, et al. · Nature Medicine · 30
Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021
2022 · Zhanpeng Ou, Ling Qiu, et al. · Frontiers in Immunology · 24
PDF
Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma
2025 · Lizao Zhang, Siqi Ren, et al. · OncoImmunology · 15
PDF
Correlation Between TCF7+ T Cells and Prognosis of Patients With Oral Squamous Cell Carcinoma
2022 · Haixu Rong, Tingting Cai, et al. · Frontiers in Oncology · 7
PDF
Front Cover
2025 · Bin Wei, Guoxiong Lu, et al. · Head & Neck · 1
PDF
Characteristic of Immunotherapy Trials in Head and Neck Squamous Cell Carcinoma: 2013–2023
2025 · Binbin Xia, Fan Wu, et al. · Oral Diseases · 1
PDF
Clinical-Knowledge-Driven Prompt-Tuning for Predicting Occult Lymph Node Metastasis in Early-Stage Head and Neck Cancer: A Multicenter MRI-Based Study
2026 · Ling Qiu, Guangzi Shi, et al. · SSRN Electronic Journal
Finder‐I for Locating Anterolateral Thigh Perforators in Head and Neck Reconstruction: A Diagnostic Study
2025 · Bin Wei, Guoxiong Lu, et al. · Head & Neck
Author response for "Characteristic of Immunotherapy Trials in Head and Neck Squamous Cell Carcinoma: 2013–2023"
2024 · Binbin Xia, Fan Wu, et al.
Reversing Immunosenescence with Senolytics to Enhance Tumor Immunotherapy
2024 · Niu Liu, Jiaying Wu, et al. · medRxiv
PDF
[Surgical treatment for perihilar cholangiocarcinoma:a single-center experience].
2023 · W Y Deng, X D Shi, et al. · PubMed
Works count: 12
Citation count: 134
H-index: 5
I10-index: 4
Year
Topic
Type